Kosuke Ichikawa

发表

Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients

Shujiro Okuda, P. Schraml, A. Miyashita, 2020, Cells.

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2022, Scientific reports.

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Frontiers in Oncology.

Usefulness of EBUS-TBNA in the Staging of Lung Cancer in Patients with Sarcoidosis and Sarcoid Reactions

Kosuke Ichikawa, T. Kikuchi, Satoshi Watanabe, 2018 .

Prognostic significance of procalcitonin in small cell lung cancer

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

Kazuhiro Sato, Hiroshi Tanaka, Kosuke Ichikawa, 2018, Oncology.

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Cancer Immunology, Immunotherapy.

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2017, PloS one.

immunity during recovery from lymphopenia Depletion of radio-resistant regulatory T cells enhances antitumor

I. Narita, K. Nakata, Hiroshi Tanaka, 2013 .

Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases

Kazuhiro Sato, T. Ishida, Hiroshi Tanaka, 2019, Thoracic cancer.

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy

I. Narita, K. Nakata, Daisuke Ishikawa, 2015, The Journal of Immunology.

after Lymphodepleting Chemotherapy Regulatory T Cells in Antitumor Immunity Critical Roles of Chemoresistant Effector and

K. Nakata, Daisuke Ishikawa, Kosuke Ichikawa, 2015 .

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Translational lung cancer research.

Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy

Kazuhiro Sato, T. Ishida, Hiroshi Tanaka, 2020, Cancer medicine.

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

I. Narita, Kosuke Ichikawa, H. Kagamu, 2012, Vaccine.

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC

Daisuke Ishikawa, Hiroshi Tanaka, Kosuke Ichikawa, 2021, Scientific reports.

Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer

T. Ishizuka, T. Higuchi, K. Kaira, 2022, Scientific reports.

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations

Y. Ajioka, Hiroshi Tanaka, Miyuki Sato, 2019, PloS one.

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Scientific Reports.

HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features

M. Horinaka, T. Sakai, Ryohei Katayama, 2022, npj Precision Oncology.

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Rie Kondo, Junko Baba, Hiroshi Kagamu, 2011, BMC Cancer.

Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer

T. Ishizuka, T. Higuchi, K. Kaira, 2023, Cancer Imaging.

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Kazuhiro Sato, T. Ishida, Hiroshi Tanaka, 2021, Translational lung cancer research.

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

I. Narita, K. Nakata, Hiroshi Tanaka, 2012, Blood.

Vaccination with CD133+ melanoma induces specific Th17 and Th1 cell–mediated antitumor reactivity against parental tumor

I. Narita, K. Nakata, Hiroshi Tanaka, 2011, Cancer Immunology, Immunotherapy.

Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer

T. Ishizuka, T. Higuchi, K. Kaira, 2022, Scientific Reports.

Disseminated Varicella-zoster Virus Infection Causing Fatal Pneumonia in an Immunocompromised Patient with Chronic Interstitial Pneumonia

Y. Ajioka, R. Ohashi, T. Abé, 2020, Internal medicine.

Development of a video image-based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system.

Ryuta Baba, Laurence Court, Satoru Sugimoto, 2015, Medical physics.

Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer.

T. Honda, M. Komatsu, Hiroshi Yamamoto, 2015, Internal medicine.

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.

I. Narita, K. Nakata, Hiroshi Tanaka, 2012, Blood.